85% of patients for Rare Diseases screening selected via Danny Analytics

Empowering physicians in real-time to identify eligible patients for Pompe, Gaucher, and Fabry screening via Danny Analytics AI algorithm

Sqilline and a leading pharmaceutical company have partnered to apply Big Data technologies for the screening of patients for rare diseases to expedite diagnosis by finding previously undiagnosed patients.

CHALLENGES:

  • Limited awareness of doctors, patients, and their relatives
  • Symptoms – interpreted in the context of common diseases
  • Average 4.8 Yrs. for a patient with a rare disease to reach an accurate diagnosis

BENEFITS FOR PHYSICIANS:

  • Enabling physicians quickly to identify patients for early diagnosis and timely treatment
  • Improves collaboration and awareness of the disease among the hospitals in the country
  • Better clinical and patient-oriented outcomes

WHY DANNY ANALYTICS:

  • Embedded ML algorithms allow the platform to extract and search by keywords from the enormous volume of unstructured/free text from the epicrisis
  • Using pre-defined inclusion and exclusion criteria, the eligible patients are selected in real-time
  • Automatically alert physicians when new, high-risk patients are added to an appropriate screening cohort

Machine-learning technologies can offer great opportunities in the process of screening for rare disease patients.

Analyzing through Big Data who may fit the testing criteria can expedite the diagnostic delay.

This can offer patients more effective therapy if started in the early stages of the disease.

Share this article:

More News & Highlights

News

What if we could change the common approach to clinical trials?

Desislava Mihaylova, CEO and Founder, Sqilline At Sqilline, we listen to the people we work with and often ask ourselves what if… This was the...

Read more...

Highlights

Breaking Barriers in Healthcare Data Interoperability: The Danny Platform Solutions

Mihail Jekov, CTO and Partner, Sqilline Electronic Health Records (EHRs) contain a large quantity of machine-readable data. However, institutions choose different EHR vendors, and the...

Read more...

News

Sqilline and Fundeni Clinical Institute unite through a strategic partnership for access to high-quality Real-World Data

Sqilline is proud to announce its partnership with The Fundeni Clinical Institute in Romania. The focus of this partnership is the deployment of the analytic...

Read more...